J. David Hansen

2015

In 2015, J. David Hansen earned a total compensation of $4.2M as President, Chief Executive Officer and Chairman at MabVax Therapeutics Holdings, a 1,021% increase compared to previous year.

Compensation breakdown

Bonus$149,625
Option Awards$1,493,194
Salary$375,601
Stock Awards$2,077,475
Other$87,770
Total$4,183,665

Hansen received $2.1M in stock awards, accounting for 50% of the total pay in 2015.

Hansen also received $149.6K in bonus, $1.5M in option awards, $375.6K in salary and $87.8K in other compensation.

Rankings

In 2015, J. David Hansen's compensation ranked 2,060th out of 13,638 executives tracked by ExecPay. In other words, Hansen earned more than 84.9% of executives.

ClassificationRankingPercentile
All
2,060
out of 13,638
85th
Division
Manufacturing
736
out of 5,187
86th
Major group
Chemicals And Allied Products
266
out of 1,857
86th
Industry group
Drugs
209
out of 1,531
86th
Industry
Pharmaceutical Preparations
167
out of 1,179
86th
Source: SEC filing on May 2, 2017.

Hansen's colleagues

We found three more compensation records of executives who worked with J. David Hansen at MabVax Therapeutics Holdings in 2015.

2015

Gregory Hanson

MabVax Therapeutics Holdings

Chief Financial Officer

2015

Paul Maffuid

MabVax Therapeutics Holdings

Vice President, Pharmaceutical Development and Operations

2015

Wolfgang Scholz

MabVax Therapeutics Holdings

Vice President, Antibody Discovery

You may also like